211: Biotech's catch-22, a $100 genome, & dealing with monkeypox
The Readout Loud
00:00
What Do You Expect From Biote?
I think we're at a point in which anything positive should have some sort of an uplifting impact on the broader group. I'm looking some companies that have already provided a glimpse into their data, a gilead morati, iovance a, p m v farma. There's a couple others that i feel like, because of the way that the markets work, are going to be scrutinized more than others.
Transcript
Play full episode
